Operating

Change in AP

Alnylam Pharmaceuticals Change in AP decreased by 178.8% to -$176.03M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 11.6%, from -$157.74M to -$176.03M. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalHigher is better
VolatilityVolatile
First reportedQ4 2013
Last reportedQ4 2025

How to read this metric

An increase suggests the company is successfully leveraging its scale to negotiate better payment terms with its supply chain.

Detailed definition

Accounts payable represents the change in the amount the company owes to its suppliers for materials or services purchas...

Peer comparison

Dominant market leaders often have high accounts payable as they can dictate longer payment terms to their vendors.

Metric ID: change_in_accounts_payable

Historical Data

17 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$68.95M$46.36M$39.50M-$48.74M$68.14M$69.75M$102.62M-$81.98M$82.74M$118.74M-$4.87M$74.47M$83.60M-$157.74M$184.15M$223.51M-$176.03M
QoQ Change-32.8%-14.8%-223.4%+239.8%+2.4%+47.1%-179.9%+200.9%+43.5%-104.1%>999%+12.3%-288.7%+216.7%+21.4%-178.8%
YoY Change-1.2%+50.4%+159.8%-68.2%+21.4%+70.2%+94.1%-10.0%-29.6%<-999%+147.3%+167.4%-11.6%
Range-$176.03M$223.51M
CAGR+26.4%
Avg YoY Growth-196.3%
Median YoY Growth+21.4%

Frequently Asked Questions

What is Alnylam Pharmaceuticals's change in ap?
Alnylam Pharmaceuticals (ALNY) reported change in ap of -$176.03M in Q1 2026.
How has Alnylam Pharmaceuticals's change in ap changed year-over-year?
Alnylam Pharmaceuticals's change in ap decreased by 11.6% year-over-year, from -$157.74M to -$176.03M.
What does change in ap mean?
The change in the amount of money the company owes to its suppliers.